ANAniceto Lopes da Silva Neto
Aniceto Lopes da Silva Neto
*This is an algorithmically generated author record based on publicly available information.
Aniceto Lopes da Silva Neto has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Mariana Scaranti
Hospital 9 de Julho - Américas Oncologia, São Paulo, Brazil
5 shared publications Juliana Mandarano de Mattos
Hospital 9 de Julho- Américas Oncologia, Clinical Oncology, São Paulo, Brazil
3 shared publications- Mariana Carvalho Gouveia
Yale University, Department of Medical Oncology, New Haven, CT, USA; Hospital 9 de Julho-Américas Oncologia, Department of Medical Oncology, São Paulo, Brazil; Early Career Editorial Board Member, International Journal of Gynecological Cancer
3 shared publications - Juliana Mandarano de Mattos
Hospital 9 de Julho - Américas Oncologia, São Paulo, Brazil
2 shared publications Adriana Kahn
Yale School of Medicine, Yale Cancer Center, New Haven, CT, USA
1 shared publicationAmanda de Araújo Dias
Hospital 9 de Julho-Américas Oncologia, São Paulo, Brazil
1 shared publication
Latest Publications
- 16 June 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (8) , 104813
ASCO Annual Meeting 2026: Key Clinical Trial Updates in Gynecologic Oncology
- 16 June 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (8) , 104813
ASCO Annual Meeting 2026: Key Clinical Trial Updates in Gynecologic Oncology
- 8 May 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (8) , 104747
Between biology and benefit: who gains from PARP-immunotherapy in p53-abnormal endometrial cancer?
- 8 May 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (8) , 104747
Between biology and benefit: who gains from PARP-immunotherapy in p53-abnormal endometrial cancer?
- 16 April 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (6) , 104705
From metformin to glucagon-like peptide-1 receptor agonists: can metabolic modulation enhance progestin therapy for endometrial cancer?
- 16 April 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (6) , 104705
From metformin to glucagon-like peptide-1 receptor agonists: can metabolic modulation enhance progestin therapy for endometrial cancer?
- 28 March 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (5) , 104672
Breast cancer risk after ovarian cancer in patients with BRCA mutations: Implications in an era of improving survival
- 28 March 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (5) , 104672
Breast cancer risk after ovarian cancer in patients with BRCA mutations: Implications in an era of improving survival
- 7 February 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (4) , 104548
Less can be more—until biology says otherwise: lessons from PORTEC-4a
- 7 February 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (4) , 104548
Less can be more—until biology says otherwise: lessons from PORTEC-4a